Worldwide Fascioliasis Treatment Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4354914
- 116 Pages
- March 2021
- Healthcare
Fascioliasis is a parasitical infection triggered by fasciola hepatica and fasciola massive which is transmitted using infected water as well as raw veggies. it contaminates human beings, livestock as well as sheep.
Fascioliasis has actually demonstrated signs and symptoms of nausea or vomiting, abdominal discomfort, vomiting, intermitted fever, eosinophilia as well as hepatomegaly. according to the globe health and wellness organisation (that), fascioliasis has been reported in even more than 75 countries worldwide with the prevalent infected global populace of 2.4 million, without single country is risk-free of fascioliasis.
The badly impacted locations include south America, east-Asia, and south-east Asia. endangered health as well as hygiene are the crucial reasons for the infections. the signs and symptoms are noticeable at 9-11 weeks of infections.
The medical diagnosis includes eosinophil count (>> 500 ; 1000 per microlitre of blood), computer tomography scans as well as ultrasound. the accepted medication for fascioliasis is triclabendazole.
Coronavirus pandemic has actually jolted the market. nations like China contaminated originally by coronavirus which is the significant global vendor of active pharmaceutical ingredients and also chemicals. this has actually detrimentally affected the fascioliasis treatment market.
Although, the worldwide fascioliasis treatment market is expected to speed with rewarding growth surge with the remediation of normal scenario, and also with the continuous progressive market augmentations.
Fascioliasis treatment market: chauffeurs as well as restraints
The international fascioliasis treatment market is driven by the surging international fascioliasis problems which are because of the close call with animals, widespread in the, Latin America, Europe, south Asia, eastern Asia, oceania as well as mea.
Because these countries are greatly based on livestock as well as sheep for food and also agriculture. the revamping healthcare centers, increasing understanding, non reusable earnings and also the development of r& d for fascioliasis therapy medications are sustaining the market.
Federal government has a number of dedicated encouraging systems in addition to that to enhance the understanding of therapies, subsidized medications as well as reimbursement plans. government has active funding aids as well as programs to support the merging medicine suppliers for fascioliasis therapy.
Nevertheless, the minimal medicines, dose problems, damaging responses, resistances and longer drug period are the restraints for the worldwide fascioliasis treatment market.
Although dedicated medicine manufactures are pondering to reduce the price of medicines such as triclabendazole. additionally, development of even more efficient and also safer medicines such as nitazoxanide, niclofolan emetine, chloroquine and also heptachlor-para-xylol are underway after the recommendation by who.
Fascioliasis therapy market: review
The global fascioliasis treatment market is anticipated with a profitable growth in future with the current modern augmentation of the marketplace, the surging invasions as well as medication demands. by therapy, triclabendazole regulations the marketplace as being the major medication for fascioliasis, works for both intense as well as chronic fascioliasis, with high effectiveness and light negative impacts.
Nitazoxanide is understudy to create as a more secure medication and also its market is expanding at a quicker price. by distribution channels, health center drug store is the largest market of fascioliasis treatment, driven by the physicians medical diagnosis and prescriptions, reimbursements as well as federal government connections.
Fascioliasis therapy market: local outlook
The global fascioliasis therapy market is controlled by Latin America with the raising instances of fascioliasis due to the hefty contact with animals, endangered hygiene and also boosting recognition. the regions driving the Latin America fascioliasis therapy market include Peru, Chile, Argentina and bolivia, with raising frequency of fascioliasis, federal government help and therapy accessibility.
Center eastern & Africa fascioliasis therapy market are likewise arising because of the rising cases in Africa, egypt, zimbabwe, cameroon and senegal, coupled with the federal government help. Asia pacific region is likewise boosting because of south-Asian nations such as India, bangladesh, vietnam as well as east oriental countries with increasing burden of fascioliasis, bad cleanliness and therapy schedule.
However, Europe and the United States and Canada have minimal fascioliasis therapy market as well as laggard growth rate due to reduced cases, strict sanitation and hygiene, as well as food criteria.
Fascioliasis therapy market: essential players
The principals of worldwide fascioliasis treatment market consist of
Novartis
Alivira pet wellness limited
Merck & co.
Janssen
Hebei veyong pharmaceutical co. ltd
Norbrook
Pfizer
Procyon life sciences
Ipca labs and hangzhou believe chemical co. ltd.
The research report presents a thorough evaluation of the market as well as includes thoughtful insights, truths, historical data, and also statistically supported and industry-validated market information.
It also contains forecasts making use of a suitable set of presumptions and techniques. the research report offers evaluation and details according to market sections such as geographies, application, as well as sector.
The report covers exhaust evaluation on:
Market sectors
Market dynamics
Market size
Supply & demand existing trends/issues/challenges
Competition & business involved
Sign
Value chain
Regional analysis consists of:
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, UK, Spain)
Eastern Europe (Poland, Russia)
Asia-pacific omitting Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Center east and Africa (GCC nations, south Africa, north Africa)
The report is a compilation of first-hand info, qualitative and measurable analysis by market experts, inputs from industry experts and industry participants throughout the value chain. the record provides in-depth evaluation of parent market trends, macro-economic indications as well as governing variables together with market beauty according to sections. the record additionally maps the qualitative influence of various market elements on market sections and geographies.
Report highlights:
Comprehensive overview of parent market
Transforming market characteristics in the sector
In-depth market segmentation
Historic, existing, as well as projected market dimension in regards to quantity and worth
Current market fads and growths
Competitive landscape
Approaches of essential gamers and products provided
Potential as well as particular niche segments, geographical areas exhibiting appealing development
A neutral point of view on market performance
Essential details for market gamers to sustain and also improve their market footprint.
Fascioliasis treatment market: segmentation
The international fascioliasis treatment market can be fractional into therapy as well as distribution networks.
Treatment
Triclabendazole
Nitazoxanide
Circulation network
Health center pharmacy
On-line drug store
Retail pharmacy
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Fascioliasis Treatment by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Fascioliasis Treatment Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Fascioliasis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Fascioliasis Treatment Production from 2014-2020
4.3.1.2 North America Fascioliasis Treatment Consumption from 2014-2020
4.3.1.3 North America Fascioliasis Treatment Import and Export from 2014-2020
4.3.1.4 North America Fascioliasis Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Fascioliasis Treatment Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Fascioliasis Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Fascioliasis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Fascioliasis Treatment Production from 2014-2020
4.3.2.2 Europe Fascioliasis Treatment Consumption from 2014-2020
4.3.2.3 Europe Fascioliasis Treatment Import and Export from 2014-2020
4.3.2.4 Europe Fascioliasis Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Fascioliasis Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Fascioliasis Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Fascioliasis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Fascioliasis Treatment Production from 2014-2020
4.3.3.2 Asia-Pacific Fascioliasis Treatment Consumption from 2014-2020
4.3.3.3 Asia-Pacific Fascioliasis Treatment Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Fascioliasis Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Fascioliasis Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Fascioliasis Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Fascioliasis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Fascioliasis Treatment Production from 2014-2020
4.3.4.2 Latin America Fascioliasis Treatment Consumption from 2014-2020
4.3.4.3 Latin America Fascioliasis Treatment Import and Export from 2014-2020
4.3.4.4 Latin America Fascioliasis Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Fascioliasis Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Fascioliasis Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Fascioliasis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Fascioliasis Treatment Production from 2014-2020
4.3.5.2 Middle East & Africa Fascioliasis Treatment Consumption from 2014-2020
4.3.5.3 Middle East & Africa Fascioliasis Treatment Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Fascioliasis Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Fascioliasis Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Fascioliasis Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Fascioliasis Treatment Market from 2020-2026
7.1 Future Forecast of Global Fascioliasis Treatment Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Fascioliasis Treatment Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Fascioliasis Treatment Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
427 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Fascioliasis Treatment Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Fascioliasis Treatment Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Fascioliasis Treatment
Figure Type 2 of Fascioliasis Treatment
Figure Type 3 of Fascioliasis Treatment
Table Global Fascioliasis Treatment Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Fascioliasis Treatment Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Fascioliasis Treatment
Figure Application 2 of Fascioliasis Treatment
Figure Application 3 of Fascioliasis Treatment
Table Global Fascioliasis Treatment Production Value ($) by Regions
Table Global Fascioliasis Treatment Production Value Share by Regions
Table Global Fascioliasis Treatment Production by Regions
Table Global Fascioliasis Treatment Production Share by Regions
Table Global Fascioliasis Treatment Consumption by Regions
Table Global Fascioliasis Treatment Consumption Share by Regions
Figure North America Fascioliasis Treatment Production and Growth Rate from 2014-2020
Figure North America Fascioliasis Treatment Consumption and Growth Rate from 2014-2020
Table North America Fascioliasis Treatment Import and Export from 2014-2020
Table North America Fascioliasis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table North America Fascioliasis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table North America Fascioliasis Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
Figure Europe Fascioliasis Treatment Production and Growth Rate from 2014-2020
Figure Europe Fascioliasis Treatment Consumption and Growth Rate from 2014-2020
Table Europe Fascioliasis Treatment Import and Export from 2014-2020
Table Europe Fascioliasis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Europe Fascioliasis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Europe Fascioliasis Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Fascioliasis Treatment Production and Growth Rate from 2014-2020
Figure Asia-Pacific Fascioliasis Treatment Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Fascioliasis Treatment Import and Export from 2014-2020
Table Asia-Pacific Fascioliasis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Fascioliasis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Fascioliasis Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
Figure Latin America Fascioliasis Treatment Production and Growth Rate from 2014-2020
Figure Latin America Fascioliasis Treatment Consumption and Growth Rate from 2014-2020
Table Latin America Fascioliasis Treatment Import and Export from 2014-2020
Table Latin America Fascioliasis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Fascioliasis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Fascioliasis Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Fascioliasis Treatment Production and Growth Rate from 2014-2020
Figure Middle East & Africa Fascioliasis Treatment Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Fascioliasis Treatment Import and Export from 2014-2020
Table Middle East & Africa Fascioliasis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Fascioliasis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Fascioliasis Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Fascioliasis Treatment Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Fascioliasis Treatment Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Fascioliasis Treatment Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Fascioliasis Treatment Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Fascioliasis Treatment Production and Growth Rate Forecast by Types (2020-2026)
Table Global Fascioliasis Treatment Consumption and Growth Rate Forecast by End-User/Applications (2020-2444)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
